| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |